Ligand validation:7PHE

VAK: methyl (1R,2R,4S)-2-ethyl-2,4,5,7-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

VAK is a Ligand Of Interest in 7PHE designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7PHE_VAK_B_401	54%	15%	0.169	0.933	2.53	1.24	8	4	0	0	100%	0.98
7PHE_VAK_A_401	37%	15%	0.201	0.897	2.51	1.31	8	4	1	0	100%	0.97
7PGA_VAK_A_402	12%	7%	0.314	0.849	2.54	2.2	9	5	11	0	100%	0.86
7PHF_VAK_D_402	1%	12%	0.459	0.663	2.46	1.61	7	5	18	0	100%	0.83
3IHG_VAK_B_537	62%	17%	0.15	0.941	2.19	1.45	9	8	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.